Loss of CDX2 expression was detected in 10% of the tumours, which is comparable to several previous studies.5,6,10,11,14–16 Differences may be related to the cut-off defining a CDX2-negative tumour and the investigated tumour specimens. Here, CDX2 is linked to neoplasm.